A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma

Diffuse Intrinsic Pontine Glioma

Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors FUS Etoposide for DMG – A Feasibility Study Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma Expanded Access to OKN-007 for Patients With Diffuse Midline Glioma, H3 K27-altered A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0 A Phase 1/2 Study of SONALA-001 and Exablate 4000 Type 2 in Patients With DIPG A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma and H3 K27M-Mutant High-Grade Glioma 131I-omburtamab Delivered by Convection-Enhanced Delivery in Patients With Diffuse Intrinsic Pontine Glioma Combination Therapy for the Treatment of Diffuse Midline Gliomas rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG Precision Medicine and Adoptive Cellular Therapy Non-Invasive Focused Ultrasound (FUS) With Oral Panobinostat in Children With Progressive Diffuse Midline Glioma (DMG) A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) Neoantigen Vaccine Therapy Against H3.3-K27M Diffuse Intrinsic Pontine Glioma HRQL and Symptom Assessment for Patients With DIPG or Recurrent and Re-irradiated Brain Tumours and Their Caregivers 9-ING-41 in Pediatric Patients With Refractory Malignancies. Nimotuzumab in Combined With Concurrent Radiochemotherapy in the Treatment of Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Children Nimotuzumab in Children With Intrinsic Pontine Glioma CED of MTX110 Newly Diagnosed Diffuse Midline Gliomas Gemcitabine in Newly-Diagnosed Diffuse Midline Glioma A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas A Study of DSP-7888 in Pediatric Patients With Relapsed or Refractory High Grade Gliomas C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B) A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG) REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma A Study of Ad-RTS-hIL-12 + Veledimex in Pediatric Subjects With Brain Tumors or DIPG A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas ONC201 in Pediatric H3 K27M Gliomas Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas Study of Re-irradiation at Relapse Versus RT and Multiple Elective rt Courses Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma Study of the Combination of Crizotinib and Dasatinib in Pediatric Research Participants With Diffuse Pontine Glioma (DIPG) and High-Grade Glioma (HGG) Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma Molecular Profiling for Individualized Treatment Plan for DIPG A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas Hypofractionated Radiotherapy for Recurrent DIPG Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma Re-Irradiation of Progressive or Recurrent DIPG Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) Gemcitabine in Newly-Diagnosed Diffuse Intrinsic Pontine Glioma Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma Intra-arterial Chemotherapy for the Treatment of Progressive Diffuse Intrinsic Pontine Gliomas (DIPG). CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With Diffuse Intrinsic Pontine Glioma (DIPG) International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository